| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 153, Issue 5 2102-2109, Copyright © 1994 by American Association of Immunologists
ARTICLES |
T Takahashi, Y Makiguchi, Y Hinoda, H Kakiuchi, N Nakagawa, K Imai and A Yachi
First Department of Internal Medicine, Sapporo Medical University School of Medicine, Japan.
Polymorphic epithelial mucin (MUC1) was detected in myeloma cells and in sera of multiple myeloma patients. HLA-unrestricted CTL that recognize tumor-associated epitopes on MUC1 has been shown to be induced from breast and pancreas cancer patients. To investigate whether such CTL can also be induced from multiple myeloma patients, an allogeneic mixed leukocyte tumor cell culture was performed. PBMCs of a multiple myeloma patient were stimulated by different allogeneic breast carcinoma and myeloma cell lines. The cultured PBMCs were proliferated and a CTL line TN was established. TN exclusively expressed TCR- alpha/beta, CD3, and CD8. TN lysed breast carcinoma and myeloma cell lines but did not lyse K562, which is sensitive to NK cells. The cytotoxicity of TN was inhibited by anti-CD3 Abs but not by anti-HLA Abs. Thus, the TCR-alpha/beta was considered to be involved in the recognition of the target cells but HLA was not. Furthermore, TN lysed transformed mouse fibroblast cells transfected with MUC1 cDNA, suggesting that this CTL line recognizes MUC1 directly. Thus, it is concluded that precursors of HLA-unrestricted and anti-MUC1 reactive CTL could exist in the peripheral blood of multiple myeloma patients and that myeloma cells can express epitopes on MUC1, which can be recognized by the CTL.
This article has been cited by other articles:
|
|
 |
|
  T. Kawano, M. Ito, D. Raina, Z. Wu, J. Rosenblatt, D. Avigan, R. Stone, and D. Kufe MUC1 Oncoprotein Regulates Bcr-Abl Stability and Pathogenesis in Chronic Myelogenous Leukemia Cells Cancer Res., December 15, 2007; 67(24): 11576 - 11584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Pochampalli, B. G. Bitler, and J. A. Schroeder Transforming Growth Factor {alpha} Dependent Cancer Progression Is Modulated by Muc1 Cancer Res., July 15, 2007; 67(14): 6591 - 6598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Huang, D. Chen, D. Liu, L. Yin, S. Kharbanda, and D. Kufe MUC1 Oncoprotein Blocks Glycogen Synthase Kinase 3{beta}-Mediated Phosphorylation and Degradation of {beta}-Catenin Cancer Res., November 15, 2005; 65(22): 10413 - 10422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Levitin, O. Stern, M. Weiss, C. Gil-Henn, R. Ziv, Z. Prokocimer, N. I. Smorodinsky, D. B. Rubinstein, and D. H. Wreschner The MUC1 SEA Module Is a Self-cleaving Domain J. Biol. Chem., September 30, 2005; 280(39): 33374 - 33386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Choi, M. Witzens, M. Bucur, M. Feuerer, N. Sommerfeldt, A. Trojan, A. Ho, V. Schirrmacher, H. Goldschmidt, and P. Beckhove Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma Blood, March 1, 2005; 105(5): 2132 - 2134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Vasir, D. Avigan, Z. Wu, K. Crawford, S. Turnquist, J. Ren, and D. Kufe Dendritic Cells Induce MUC1 Expression and Polarization on Human T Cells by an IL-7-Dependent Mechanism J. Immunol., February 15, 2005; 174(4): 2376 - 2386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Mukherjee, T. L. Tinder, G. D. Basu, and S. J. Gendler MUC1 (CD227) interacts with lck tyrosine kinase in Jurkat lymphoma cells and normal T cells J. Leukoc. Biol., January 1, 2005; 77(1): 90 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-Y. Tsang, C. Palena, J. Gulley, P. Arlen, and J. Schlom A Human Cytotoxic T-Lymphocyte Epitope and Its Agonist Epitope from the Nonvariable Number of Tandem Repeat Sequence of MUC-1 Clin. Cancer Res., March 15, 2004; 10(6): 2139 - 2149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Wajchman, C. W. Pierce, V. A. Varma, M. M. Issa, J. Petros, and K. E. Dombrowski Ex Vivo Expansion of CD8+CD56+ and CD8+CD56- Natural Killer T Cells Specific for MUC1 Mucin Cancer Res., February 1, 2004; 64(3): 1171 - 1180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hayashi, T. Hideshima, M. Akiyama, N. Raje, P. Richardson, D. Chauhan, and K. C. Anderson Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytes Blood, August 15, 2003; 102(4): 1435 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Wei and S Juneja Bone marrow immunohistology of plasma cell neoplasms J. Clin. Pathol., June 1, 2003; 56(6): 406 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Milazzo, V. L. Reichardt, M. R. Muller, F. Grunebach, and P. Brossart Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA Blood, February 1, 2003; 101(3): 977 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Higashi, K. Fujioka, K. Denda-Nagai, S.-i. Hashimoto, S. Nagai, T. Sato, Y. Fujita, A. Morikawa, M. Tsuiji, M. Miyata-Takeuchi, et al. The Macrophage C-type Lectin Specific for Galactose/N-Acetylgalactosamine Is an Endocytic Receptor Expressed on Monocyte-derived Immature Dendritic Cells J. Biol. Chem., May 31, 2002; 277(23): 20686 - 20693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R L Ten Berge, F G M Snijdewint, S von Mensdorff-Pouilly, R J J Poort-Keesom, J J Oudejans, J W R Meijer, R Willemze, J Hilgers, and C J L M Meijer MUC1 (EMA) is preferentially expressed by ALK positive anaplastic large cell lymphoma, in the normally glycosylated or only partly hypoglycosylated form J. Clin. Pathol., December 1, 2001; 54(12): 933 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Brossart, A. Schneider, P. Dill, T. Schammann, F. Grunebach, S. Wirths, L. Kanz, H.-J. Buhring, and W. Brugger The Epithelial Tumor Antigen MUC1 Is Expressed in Hematological Malignancies and Is Recognized by MUC1-specific Cytotoxic T-Lymphocytes Cancer Res., September 1, 2001; 61(18): 6846 - 6850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Stockl, O. Majdic, G. Fischer, D. Maurer, and W. Knapp Monomorphic Molecules Function as Additional Recognition Structures on Haptenated Target Cells for HLA-A1-Restricted, Hapten-Specific CTL J. Immunol., September 1, 2001; 167(5): 2724 - 2733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. E. Franke, S. Kraus, C. Eiermann, K. Pauls, E.-N. Lalani, and M. Bergmann MUC1 in normal and impaired spermatogenesis Mol. Hum. Reprod., June 1, 2001; 7(6): 505 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Treon, P. Maimonis, D. Bua, G. Young, N. Raje, J. Mollick, D. Chauhan, Y.-T. Tai, T. Hideshima, Y. Shima, et al. Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma Blood, November 1, 2000; 96(9): 3147 - 3153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Gilles, A. Goy, Y. Remache, P. Shue, and A. D. Zelenetz MUC1 dysregulation as the consequence of a t(1;14)(q21;q32) translocation in an extranodal lymphoma Blood, May 1, 2000; 95(9): 2930 - 2936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. G. Dyomin, N. Palanisamy, K. O. Lloyd, K. Dyomina, S. C. Jhanwar, J. Houldsworth, and R. S. K. Chaganti MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets Blood, April 15, 2000; 95(8): 2666 - 2671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Brossart, K. S. Heinrich, G. Stuhler, L. Behnke, V. L. Reichardt, S. Stevanovic, A. Muhm, H.-G. Rammensee, L. Kanz, and W. Brugger Identification of HLA-A2-Restricted T-Cell Epitopes Derived From the MUC1 Tumor Antigen for Broadly Applicable Vaccine Therapies Blood, June 15, 1999; 93(12): 4309 - 4317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Komatsu, L. Yee, and K. L. Carraway Overexpression of Sialomucin Complex, a Rat Homologue of MUC4, Inhibits Tumor Killing by Lymphokine-activated Killer Cells Cancer Res., May 1, 1999; 59(9): 2229 - 2236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Pellat-Deceunynck, G. Jego, J.-L. Harousseau, H. Vie, and R. Bataille Isolation of Human Lymphocyte Antigens Class I-restricted Cytotoxic T Lymphocytes against Autologous Myeloma Cells Clin. Cancer Res., March 1, 1999; 5(3): 705 - 709. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Treon, J. A. Mollick, M. Urashima, G. Teoh, D. Chauhan, A. Ogata, N. Raje, J. H.M. Hilgers, L. Nadler, A. R. Belch, et al. Muc-1 Core Protein Is Expressed on Multiple Myeloma Cells and Is Induced by Dexamethasone Blood, February 15, 1999; 93(4): 1287 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Teoh, L. Chen, M. Urashima, Y.-T. Tai, L. A. Celi, D. Chen, D. Chauhan, A. Ogata, R. W. Finberg, I. J. Webb, et al. Adenovirus Vector-Based Purging of Multiple Myeloma Cells Blood, December 15, 1998; 92(12): 4591 - 4601. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tarte, Z. Y. Lu, G. Fiol, E. Legouffe, J.-F. Rossi, and B. Klein Generation of Virtually Pure and Potentially Proliferating Dendritic Cells From Non-CD34 Apheresis Cells From Patients With Multiple Myeloma Blood, November 1, 1997; 90(9): 3482 - 3495. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-L. Wang, G. F. Springer, and S. C. Carlstedt Quantitative Computerized Image Analysis of Tn and T (Thomsen-Friedenreich) Epitopes in Prognostication of Human Breast Carcinoma J. Histochem. Cytochem., October 1, 1997; 45(10): 1393 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hirasawa, N. Kohno, A. Yokoyama, Y. Inoue, M. Abe, and K. Hiwada KL-6, a Human MUC1 Mucin, Is Chemotactic for Human Fibroblasts Am. J. Respir. Cell Mol. Biol., October 1, 1997; 17(4): 501 - 507. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
